Skip to main content

Growing flowers of cannabis intended for the medical marijuana market are shown at a facility in Moncton, N.B.

Ron Ward/THE CANADIAN PRESS

Globe editors have posted this research report with permission of Beacon Securities Ltd. This should not be construed as an endorsement of the report's recommendations. For more on The Globe's disclaimers please read here. The following is excerpted from the report:

Since being added to the S&P/TSX Composite Index, Canopy's shares are up 52 per cent, making it the fourth-best performing stock of the 250 in the index. Over the past three months, one month and week to date, it has been the best performing investment in the S&P/TSX Composite Index. We believe this performance is increasingly compelling larger fund managers to take a closer look at the company, want to meet with management, learn more about its business model and plans – and, for those who haven't yet, consider an investment in it.

Having hosted several break-the-ice meetings for Canopy's management with blue-chip institutions ourselves, we feel they are becoming increasingly comfortable with the company, and thus the sector at large.

Story continues below advertisement

Simply put, we feel institutional investors cannot afford to ignore this company any longer.

Read the full report here.

Globe app users click here for the full report

Read other research reports here.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter